Chronic pain and opioid misuse: a review of reviews

Pauline Voon, Mohammad Karamouzian, Thomas Kerr, Pauline Voon, Mohammad Karamouzian, Thomas Kerr

Abstract

Objective: The crisis of prescription opioid (PO) related harms has focused attention toward identifying and treating high-risk populations. This review aims to synthesize systematic reviews on the epidemiology and clinical management of comorbid chronic pain and PO or other substance misuse.

Methods: A systematic database search was conducted to identify systematic reviews published between 2000 and 2016. Eligible studies were systematic reviews related to chronic non-cancer pain and PO or other substance misuse. Evidence from the included reviews was synthesized according to epidemiology and clinical management themes.

Results: Of 1908 identified articles, 18 systematic reviews were eligible for final inclusion. Two meta-analyses estimated the prevalence of chronic non-cancer pain in individuals using POs non-medically to be approximately 48% to 60%, which is substantially higher than the prevalence of chronic non-cancer pain in general population samples (11% to 19%). Five systematic reviews estimated the rates of PO or other opioid use in chronic pain populations with substantial variation in results (0.05% to 81%), likely due to widely varying definitions of dependence, substance use disorder, misuse, addiction, and abuse. Several clinical assessment and treatment approaches were identified, including: standardized assessment instruments; urine drug testing; medication counts; prescription drug monitoring programs; blood level monitoring; treatment agreements; opioid selection; dosing and dispensing strategies; and opioid agonist treatment. However, the reviews commonly noted serious limitations, inconsistencies, and imprecision of studies, and a lack of evidence on effectiveness or clinical utility for the majority of these strategies.

Conclusion: Overall, current systematic reviews have found a lack of high-quality evidence or consistent findings on the prevalence, risk factors, and optimal clinical assessment and treatment approaches related to concurrent chronic pain and substance misuse. Given the role of systematic reviews in guiding evidence-based medicine and health policy, there is an urgent need for high-quality primary research to guide future systematic reviews to address the escalating epidemic of harms related to chronic pain and substance misuse.

Keywords: Addiction; Chronic pain; Prescription opioid; Substance use; Systematic review (3–10 keywords required).

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors have consented the current manuscript for publication.

Competing interests

The authors have no competing interests to declare.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Summary of study identification and selection

References

    1. King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review. Am J Public Health. 2014;104:e32–e42. doi: 10.2105/AJPH.2014.301966.
    1. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and Opioid overdose deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–1382. doi: 10.15585/mmwr.mm6450a3.
    1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing Opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65:1–49. doi: 10.15585/mmwr.rr6501e1.
    1. Ballantyne JC. Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain. Pain. 2015;156:567–568. doi: 10.1097/j.pain.0000000000000105.
    1. Fishbain DA, Cole B, Lewis JE, Gao J, Rosomoff RS. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med. 2009;10:829–839. doi: 10.1111/j.1526-4637.2009.00653.x.
    1. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376–380. doi: 10.7326/0003-4819-126-5-199703010-00006.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269. doi: 10.7326/0003-4819-151-4-200908180-00135.
    1. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10. doi: 10.1186/1471-2288-7-10.
    1. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, Henry DA, Boers M. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62:1013–1020. doi: 10.1016/j.jclinepi.2008.10.009.
    1. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380. doi: 10.1016/j.pain.2004.09.019.
    1. Minozzi S, Amato L, Davoli M. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction. 2013;108:688–698. doi: 10.1111/j.1360-0443.2012.04005.x.
    1. Timmerman L, Stronks DL, Groeneweg JG, Huygen FJ. Prevalence and determinants of medication non-adherence in chronic pain patients: a systematic review. Acta Anaesthesiol Scand. 2016;60:416–431. doi: 10.1111/aas.12697.
    1. Tournebize J, Gibaja V, Muszczak A, Kahn JP. Are physicians safely prescribing Opioids for chronic noncancer pain? A systematic review of current evidence. Pain Pract. 2016;16:370–383. doi: 10.1111/papr.12289.
    1. Fischer B, Lusted A, Roerecke M, Taylor B, Rehm J. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. J Pain. 2012;13:1029–1044. doi: 10.1016/j.jpain.2012.07.013.
    1. Lusted A, Roerecke M, Goldner E, Rehm J, Fischer B. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses. Pain Physician. 2013;16:E671–E684.
    1. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162:276–286. doi: 10.7326/M14-2559.
    1. Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22:173–181. doi: 10.1097/01.ajp.0000161525.48245.aa.
    1. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170:834–851. doi: 10.1176/appi.ajp.2013.12060782.
    1. Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011;152:488–497. doi: 10.1016/j.pain.2010.10.009.
    1. Wilsey BL, Fishman SM, Tsodikov A, Ogden C, Symreng I, Ernst A. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med. 2008;9:1107–1117. doi: 10.1111/j.1526-4637.2007.00401.x.
    1. Hoyt MJ, Nokes K, Newshan G, Staats JA, Thorn M. The effect of chemical dependency on pain perception in persons with AIDS. J Assoc Nurses AIDS Care. 1994;5:33–38.
    1. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag. 2007;3:89–100.
    1. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569–576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
    1. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manag. 2008;35:214–228. doi: 10.1016/j.jpainsymman.2007.03.015.
    1. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients - a systematic review and literature synthesis. Clin J Pain. 2008;24:497–508. doi: 10.1097/AJP.0b013e31816b1070.
    1. Cintron A, Morrison RS. Pain and ethnicity in the United States: a systematic review. J Palliat Med. 2006;9:1454–1473. doi: 10.1089/jpm.2006.9.1454.
    1. Dennis BB, Bawor M, Naji L, Chan CK, Varenbut J, Paul J, Varenbut M, Daiter J, Plater C, Pare G, et al. Impact of chronic pain on treatment prognosis for patients with Opioid use disorder: a systematic review and meta-analysis. Subst Abuse. 2015;9:59–80.
    1. Argoff CE, Kahan M, Sellers EM. Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence. J Opioid Manag. 2014;10:119–134. doi: 10.5055/jom.2014.0201.
    1. Eilender P, Ketchen B, Maremmani I, Saenger M, Fareed A. Treatment approaches for patients with opioid use disorder and chronic noncancer pain: a literature review. Addictive Disorders & Their Treatment. 2016;15:85–98. doi: 10.1097/ADT.0000000000000078.
    1. Becker WC, Fraenkel L, Edelman EJ, Holt SR, Glover J, Kerns RD, Fiellin DA. Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain. 2013;154:905–916. doi: 10.1016/j.pain.2013.02.031.
    1. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American pain society and American Academy of pain medicine clinical practice guideline. J Pain. 2009;10:131–146. doi: 10.1016/j.jpain.2008.10.009.
    1. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712–720. doi: 10.7326/0003-4819-152-11-201006010-00004.
    1. Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR. Family physicians' proficiency in urine drug test interpretation. J Opioid Manag. 2007;3:333–337.
    1. Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA. 2015;313:891–892. doi: 10.1001/jama.2014.18514.
    1. Bosch-Capblanch X, Abba K, Prictor M, Garner P: Contracts between patients and healthcare practitioners for improving patients' adherence to treatment, prevention and health promotion activities. Cochrane Database Syst Rev. 2007;(2):CD004808.
    1. Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: impact of the Washington state opioid dosing guideline. Am J Ind Med. 2012;55:325–331. doi: 10.1002/ajim.21998.
    1. Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, Cooper ZD, Manubay JM, Mogali S, Comer SD. Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. Pain. 2013;154:1442–1448. doi: 10.1016/j.pain.2013.05.004.
    1. Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A. Canadian guideline for safe and effective use of opioids for chronic noncancer pain - Clinical summary for family physicians. Part 2: Special populations. [French, English] Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse - Resume clinique pour les medecins de famille. Partie 2: Populations particulieres. Can Fam Physician. 2011;57:1269–1276.
    1. Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16:769–780. doi: 10.1016/j.jpain.2015.05.002.
    1. Schopflocher D, Taenzer P, Jovey R. The prevalence of chronic pain in Canada. Pain Res Manag. 2011;16:445–450. doi: 10.1155/2011/876306.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다